MedPath

Which is More Effective in Management of Bruxism: Botox or Occlusal Splints

Not Applicable
Completed
Conditions
Bruxism
Interventions
Device: overdenture
Device: occlusal splint
Registration Number
NCT04366869
Lead Sponsor
October University for Modern Sciences and Arts
Brief Summary

The aim of this study is to compare the efficacy of Botulinum toxin (Botox) and traditional occlusal splints for the management of bruxism in edentulous patients rehabilitated with MIOD

Detailed Description

42 edentulous patients having implant retained mandibular overdenture suffering from bruxism with clinical manifestation, will be randomly divided into three groups, group 1 control group (traditional approach of removing denture at night) ,group 2 will be managed by occlusal splints whereas group 3 will be managed with botulinum toxin injection (Botox). New maxillary dentures and mandibular over dentures will be constructed for both groups. Muscle activity will be measured at time of denture insertion (T0), 3(T3) 6(T6), 9(T9) and 12(T12) month of treatment. Patients satisfaction will be evaluated at the time of denture insertion (T0), 6(T6), and 12(T12) month of treatment using TMD/ NS numeric scales 10 cm questionnaire which include: headache, face pain, face tension, limitation of mouth opening and complaints during mastication.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • patients diagnosed with bruxism
  • patients had mandibular implant retained overdentures within the previous 3 years
  • cooperative patients
  • physically and psychologically able patients to tolerate the procedure
Exclusion Criteria
  • patients taking muscle relaxants
  • patients without neuromuscular control
  • poor oral hygiene

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controloverdenturetraditional approach of removing denture at night
intervention 1occlusal splintocclusal splint
intervention 2BotoxBotox
Primary Outcome Measures
NameTimeMethod
Patient satisfaction: questionnaire12months

Patients satisfaction was evaluated using TMD/ NS numeric scales 10 cm questionnaire which included: headache, face pain, face tension, limitation of mouth opening and complaints during mastication with scores from 1 to 10 whereas 1 means least pain and 10 means highest pain.it was assessed at baseline (T0), then after 3months(T3) then after 6months from baseline(T6), then after 9months from baseline(T9) and finally after 12 months from baseline (T12). which means every 3 months.

Secondary Outcome Measures
NameTimeMethod
Electromyography12 months

measuring muscle activity for massetter and temporalis muscle at baseline,3,6,9,12 months

Trial Locations

Locations (1)

MSA

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath